Semen alterations in HIV-1 infected men

Human Reproduction

Volumn 17, Issue 8, 2002, Pages 2112-2118

  Dulioust, E ^a   Le Du, A ^a   Costagliola, D ^b   Guibert, J ^a   Kunstmann, J M ^a   Heard, I ^c   Juillard, J C ^a   Salmon, D ^a   Leruez Ville, M ^d   Mandelbrot, L ^a   Rouzioux, C ^d   Sicard, D ^a   Zorn, J R ^a   Jouannet, P ^a   De Almeida, M ^a  

^a Université Paris ^*  (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

HIV 1; Semen analysis; Sperm motility

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ABSTINENCE; ADULT; AGE; ARTICLE; CELL PH; CELL STRUCTURE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; EJACULATION; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFERTILITY; INFERTILITY THERAPY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; SEMEN ABNORMALITY; SEMEN ANALYSIS; SERODIAGNOSIS; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; UTERINE TUBE DISEASE; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SPERM; TIME;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SEMEN; SPERM COUNT; TIME FACTORS;

EID: 0036673365     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.8.2112     Document Type: Article

References (32)

1. Characterization of reactive oxygen species induced effects on human spermatozoa movement and energy metabolism
2. Decline in semen quality among fertile men in Paris during the last 20 years
3. Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four european cities
4. HIV-1 particles in spermatozoa of patients with AIDS and their transfer into the oocyte
5. Detection of HIV-1 proviral in sperm from HIV-1 infected men
6. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leucocytes
7. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
8. A syndrome of lypodystrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome
9. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood
10. Semen analysis in human immunodeficiency virus infection
11. Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection
12. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
13. Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men
14. Spermatozoa as potential carriers of HIV
15. The bioenergetics of mammalian sperm motility
16. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors
17. Management of fertile and infertile HIV-positive patients wanting to become parents
18. Reactive oxygen species generated by human neutrophils inhibit sperm motility: Protective effect of seminal plasma and scavengers
19. Fertility parameters in men infected with human immunodeficiency virus
20. Semen characteristics in HIV-1 positive men and the effect of semen washing
21. Decrease of HIV seminal shedding in men receiving highly active antiretroviral therapy: An 18-month longitudinal study (ANRS EP 12)
22. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination
23. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy
24. Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1 seropositive men
25. The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seropositive men
26. Microscopic evidence against HIV-1 infection of germ cells or attachment to sperm
27. T lymphocytes and macrophages but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen
28. Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection
29. Detection and quantification of HIV-1 in semen: Evidence for a distinct population of men at high potential risk of viral sexual transmission
30. Sperm mitochondrial DNA deletions as a consequence of long term highly active antiretroviral therapy
31. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy